- €4.18m
- €14.57m
- €48.76m
- 58
- 98
- 51
- 83
Annual income statement for MedNation AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 35.5 | 35.8 | 37.5 | 45.3 | 48.8 |
| Cost of Revenue | |||||
| Gross Profit | 34.3 | 34.3 | 35.9 | 38.7 | 46 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 34.1 | 37 | 36.2 | 43.5 | 47.4 |
| Operating Profit | 1.37 | -1.16 | 1.33 | 1.81 | 1.37 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.19 | -4.1 | -1.72 | 1.03 | 0.672 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.31 | -4.22 | -1.85 | 0.55 | 0.213 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.42 | -4.4 | -1.89 | 0.481 | 0.105 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.42 | -4.4 | -1.89 | 0.481 | 0.105 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.47 | -1.46 | -0.626 | 0.16 | 0.163 |
| Dividends per Share |